Literature DB >> 19130231

Cell death: protein misfolding and neurodegenerative diseases.

Tomohiro Nakamura1, Stuart A Lipton.   

Abstract

Several chronic neurodegenerative disorders manifest deposits of misfolded or aggregated proteins. Genetic mutations are the root cause for protein misfolding in rare families, but the majority of patients have sporadic forms possibly related to environmental factors. In some cases, the ubiquitin-proteasome system or molecular chaperones can prevent accumulation of aberrantly folded proteins. Recent studies suggest that generation of excessive nitric oxide (NO) and reactive oxygen species (ROS), in part due to overactivity of the NMDA-subtype of glutamate receptor, can mediate protein misfolding in the absence of genetic predisposition. S-Nitrosylation, or covalent reaction of NO with specific protein thiol groups, represents one mechanism contributing to NO-induced protein misfolding and neurotoxicity. Here, we present evidence suggesting that NO contributes to protein misfolding via S-nitrosylating protein-disulfide isomerase or the E3 ubiquitin ligase parkin. We discuss how memantine/NitroMemantine can inhibit excessive NMDA receptor activity to ameliorate NO production, protein misfolding, and neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19130231     DOI: 10.1007/s10495-008-0301-y

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  59 in total

1.  A disease-causing mutation in the active site of serine palmitoyltransferase causes catalytic promiscuity.

Authors:  Kenneth Gable; Sita D Gupta; Gongshe Han; Somashekarappa Niranjanakumari; Jeffrey M Harmon; Teresa M Dunn
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

Review 2.  TRPC channels and their implication in neurological diseases.

Authors:  Senthil Selvaraj; Yuyang Sun; Brij B Singh
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

Review 3.  Protein S-nitrosylation: role for nitric oxide signaling in neuronal death.

Authors:  Neelam Shahani; Akira Sawa
Journal:  Biochim Biophys Acta       Date:  2011-07-23

4.  Dual neuroprotective pathways of a pro-electrophilic compound via HSF-1-activated heat-shock proteins and Nrf2-activated phase 2 antioxidant response enzymes.

Authors:  Takumi Satoh; Tayebeh Rezaie; Masaaki Seki; Carmen R Sunico; Takahito Tabuchi; Tomomi Kitagawa; Mika Yanagitai; Mutsumi Senzaki; Chihiro Kosegawa; Hideharu Taira; Scott R McKercher; Jennifer K Hoffman; Gregory P Roth; Stuart A Lipton
Journal:  J Neurochem       Date:  2011-09-21       Impact factor: 5.372

Review 5.  Misfolded proteins recognition strategies of E3 ubiquitin ligases and neurodegenerative diseases.

Authors:  Deepak Chhangani; Nihar Ranjan Jana; Amit Mishra
Journal:  Mol Neurobiol       Date:  2012-09-22       Impact factor: 5.590

6.  Nitrosylation of GAPDH augments pathological tau acetylation upon exposure to amyloid-β.

Authors:  Tanusree Sen; Pampa Saha; Nilkantha Sen
Journal:  Sci Signal       Date:  2018-03-20       Impact factor: 8.192

7.  Potential effect of S-nitrosylated protein disulfide isomerase on mutant SOD1 aggregation and neuronal cell death in amyotrophic lateral sclerosis.

Authors:  Gye Sun Jeon; Tomohiro Nakamura; Jeong-Seon Lee; Won-Jun Choi; Suk-Won Ahn; Kwang-Woo Lee; Jung-Joon Sung; Stuart A Lipton
Journal:  Mol Neurobiol       Date:  2013-10-04       Impact factor: 5.590

Review 8.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

9.  Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis.

Authors:  Diogo Martins Branco; Daniela M Arduino; A Raquel Esteves; Diana F F Silva; Sandra M Cardoso; Catarina Resende Oliveira
Journal:  Front Aging Neurosci       Date:  2010-05-21       Impact factor: 5.750

10.  BAG-6 is essential for selective elimination of defective proteasomal substrates.

Authors:  Ryosuke Minami; Atsuko Hayakawa; Hiroki Kagawa; Yuko Yanagi; Hideyoshi Yokosawa; Hiroyuki Kawahara
Journal:  J Cell Biol       Date:  2010-08-16       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.